The round also saw participation from existing investor BoxOne Ventures and includes a grant from the Chan Zuckerberg Initiative, founded by Mark Zuckerberg and Dr. Priscilla Chan, which supports essential open source software in science.
Seqera — a portmanteau of “sSeqera — a portmanteau of “sequence” and “era” – claims to have garnered massive eyeballs during the pandemic as its platform was used for the global SARS-CoV-2 sequencing efforts. “Sequencing centres and experts collaborated to develop pipelines for the analysis of COVID-19 samples using Nextflow’s platform which led to the identification and on-going surveillance of the variants including Alpha and Delta,” says the company. It processes almost all the UK’s COVID-19 data.
With the proceeds, the company plans to enhance its technological acumen and grow its North American presence.
Speaking on the development, Evan Floden, CEO and co-founder at Seqera Labs, says, “The last decade has seen an intensified demand for tools that can manage and process complex data. From personalized immunogenic vaccines to new diagnostics, our customers are performing work paramount to our global health. Joining forces with Speedinvest and Talis Capital provides us with an unparalleled opportunity to grow our reach and serve these customers better.”
Seqera has entered into the personalised medicine space which is expected to witness immense growth in the next few years. One of the company’s customers is Gritstone bio which uses Sequera’s platform Nextflow across research and production areas for machine learning workloads in their personalised oncology applications.
Sequera is focusing on the life sciences segment, but the Nextflow software can be used by companies across all computational-intense, data pipeline applications including ML and AI, manufacturing and financial services.
About Seqera Labs
Founded in 2018, Seqera Labs is a data orchestration and workflow platform which provides workflow orchestration software required for data pipeline processing, multi-cloud infrastructure provisioning, and secure collaboration.
The company’s Nextflow technology helps engineers and scientists to make and securely deploy data in the cloud and/or on traditional on-premise infrastructure. It helps in simplifying complex deployments of data analysis pipelines in multi-cloud environments, monitors and optimises drug research and discovery costs.
Seqera boasts of having six of the largest pharmaceutical companies as its customers. The Nextflow runtime has been downloaded over 2M times and the commercial cloud offering recently processed its five billionth tasks.